Faculty

Institution

Unit

Venue

Sudhir Isharwal, M.D., M.B.A.

Associate Professor of Urology School of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Urology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Department Of Urology

Division Of Pediatric Urology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Sudhir Isharwal, M.d., M.b.a. is currently serving as a Biostatistics Shared Resources Associate Professor of Urology School of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sudhir Isharwal, M.D., M.B.A.

Oregon Health & Science University

Associate Professor of Urology School of Medicine

You can click a keyword to filter the displayed items

urology oncology prostate cancer cancer care surgical oncology genitourinary cancers prostatic disease radiology medical imaging cancer imaging surgery diagnosis mri-guided radiation therapy neuroimaging reconstructive microsurgery urogynecology neuroradiology molecular cancer cancer discovery oncologic imaging minimally invasive procedures cancer treatment urological research lumen-apposing metal stent ct scan pet-mri positron emission tomography neurology neuropathology microsurgery metastasis magnetic resonance oncogenes surgical pathology jama oncology molecular diagnostics clinical proteomics biomedical imaging gastrointestinal surgery diagnostic neuroradiology robot-assisted surgery urogenital radiology medical ultrasound reconstructive urology radiation therapy clinical radiation oncology retrospective cohort studies gynecological surgery prognosis prognostic evaluation epidemiology of cancer frailty cancer genomics immune checkpoint inhibitors biomarker discovery prognostic biomarkers magnetic resonance imaging image guidance computed tomography geriatric urology pi-rads category 4 feasible option penile cancer gender representation survival outcomes off-label use practice trends primary focal therapy localized prostate cancer radical prostatectomy thailand prostate cancer tumor recognition within‐patient comparison urethral mucinous adenocarcinoma diagnostically complex disease minimal utility

Notable Scholarly Works

Notable Federal Grants

Collaborators

Early Morbidity of Retroperitoneal Lymph Node Dissection in Testicular Cancer Patients: A Retrospective Cohort Study of the National Surgical Quality Improvement Program Database. Journal of Urologic Oncology (2026)

urologysurgical oncologygynecologic cancersoncologysurgeryretrospective cohort studiescancer caregynecological surgerytesticular cancer patientsearly morbidity

Genomic and Molecular Associations With Preoperative Immune Checkpoint Inhibition in Patients With Stage III Clear Cell Renal Cell Carcinoma. Cancers (2026)

urologycancer immunotherapycancer genomicsmolecular cancergenitourinary cancersimmune checkpoint inhibitorsimmunotherapymolecular associationsimmunologycancer discoveryjama oncologykidney cancer

Editorial Comment. The Journal of Urology (2025)

Evolution Toward Early Stent Removal and Reduced Antibiotic Prophylaxis Post-Cystectomy. Canadian Journal of Urology (2025)

antibioticssurgerylumen-apposing metal stentearly stent removal

Ip05-39 Associations Between Protein Biomarkers and Adverse Pathologic Features in Mri-Mapped Prostate Cancers: An Interim Analysis. The Journal of Urology (2025)

urologymolecular diagnosticsprostatic diseasebiomarker discoverycancer discoveryan interim analysisprostate cancerprognostic biomarkersclinical proteomicspathologybiomarkers

Mp19-19 Interim Analysis of the “Shutter Speed” Mri Model to Detect Clinically Significant Prostate Cancer. The Journal of Urology (2025)

urologyprostatic diseasebiomedical imagingcancer imagingmri-guided radiation therapyoncologyradiation oncologymp19-19 interim analysisoncologic imagingcancer careprostate cancerradiologymedical imaging

Editorial Comment on “Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?”. Urology (2024)

urologysurgical oncologyeditorial commentmedicinerisk stratificationwhich indexoncologyprognosisprognostic evaluationageingcancer carebladder canceroutcomes researchepidemiology of cancermortalityfrailty

Prostate Cancer and Genetic Contributions. Andrology (2024)

urologyoncologycancer researchgenitourinary cancersoncogenescancer careprostate cancer

Utilization of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer in Elderly Patients: A Retrospective Cohort Study. Medical Oncology (2024)

urologysurgical oncologymedicinecancer researchoncologygeriatricsmuscle-invasive bladder cancergenitourinary cancersneoadjuvant chemotherapycancer carebladder cancercancer treatmentelderly patientsgeriatric urologyurological research

Mp32-06 Early Stent Removal After Radical Cystectomy. The Journal of Urology (2023)

surgerylumen-apposing metal stentmedical devicesgastrointestinal surgeryminimally invasive procedures

1
2
3
10 / page

Sudhir Isharwal, M.D., M.B.A.

Associate Professor of Urology School of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Urology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Department Of Urology

Division Of Pediatric Urology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Sudhir Isharwal, M.d., M.b.a. is currently serving as a Biostatistics Shared Resources Associate Professor of Urology School of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sudhir Isharwal, M.D., M.B.A.

Oregon Health & Science University

Associate Professor of Urology School of Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

urologysurgical oncologygynecologic cancersoncologysurgeryretrospective cohort studiescancer caregynecological surgerytesticular cancer patientsearly morbidity

Genomic and Molecular Associations With Preoperative Immune Checkpoint Inhibition in Patients With Stage III Clear Cell Renal Cell Carcinoma. Cancers (2026)

urologycancer immunotherapycancer genomicsmolecular cancergenitourinary cancersimmune checkpoint inhibitorsimmunotherapymolecular associationsimmunologycancer discoveryjama oncologykidney cancer

Editorial Comment. The Journal of Urology (2025)

Evolution Toward Early Stent Removal and Reduced Antibiotic Prophylaxis Post-Cystectomy. Canadian Journal of Urology (2025)

antibioticssurgerylumen-apposing metal stentearly stent removal

Ip05-39 Associations Between Protein Biomarkers and Adverse Pathologic Features in Mri-Mapped Prostate Cancers: An Interim Analysis. The Journal of Urology (2025)

urologymolecular diagnosticsprostatic diseasebiomarker discoverycancer discoveryan interim analysisprostate cancerprognostic biomarkersclinical proteomicspathologybiomarkers

Mp19-19 Interim Analysis of the “Shutter Speed” Mri Model to Detect Clinically Significant Prostate Cancer. The Journal of Urology (2025)

Editorial Comment on “Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?”. Urology (2024)

Prostate Cancer and Genetic Contributions. Andrology (2024)

urologyoncologycancer researchgenitourinary cancersoncogenescancer careprostate cancer

Utilization of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer in Elderly Patients: A Retrospective Cohort Study. Medical Oncology (2024)

Mp32-06 Early Stent Removal After Radical Cystectomy. The Journal of Urology (2023)

surgerylumen-apposing metal stentmedical devicesgastrointestinal surgeryminimally invasive procedures

1
2
3
10 / page